If you’ve ever worried that pharmaceutical companies have too much sway when it comes to determining your treatment, today’s news won’t help quell your fears.

The New York Times reports that a large pharmaceutical developer hired ghostwriters to “play a major role in producing” 26 scientific papers that support hormone replacement …